| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |